Skip to Content
Merck
  • Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion.

Innervation of papillary thyroid cancer and its association with extra-thyroidal invasion.

Scientific reports (2020-02-01)
Christopher W Rowe, Tony Dill, Nathan Griffin, Phil Jobling, Sam Faulkner, Jonathan W Paul, Simon King, Roger Smith, Hubert Hondermarck
ABSTRACT

Nerves are emerging regulators of cancer progression and in several malignancies innervation of the tumour microenvironment is associated with tumour aggressiveness. However, the innervation of thyroid cancer is unclear. Here, we investigated the presence of nerves in thyroid cancers and the potential associations with clinicopathological parameters. Nerves were detected by immunohistochemistry using the pan-neuronal marker PGP9.5 in whole-slide sections of papillary thyroid cancer (PTC) (nā€‰=ā€‰75), compared to follicular thyroid cancer (FTC) (nā€‰=ā€‰13), and benign thyroid tissues (nā€‰=ā€‰26). Nerves were detected in most normal thyroid tissues and thyroid cancers, but nerve density was increased in PTC (12 nerves/cm2 [IQR 7-21]) compared to benign thyroid (6 nerves/cm2 [IQR: 3-10]) (pā€‰=ā€‰0.001). In contrast, no increase in nerve density was observed in FTC. In multivariate analysis, nerve density correlated positively with extrathyroidal invasion (pā€‰<ā€‰0.001), and inversely with tumour size (pā€‰<ā€‰0.001). The majority of nerves were adrenergic, although cholinergic and peptidergic innervation was detected. Perineural invasion was present in 35% of PTC, and was independently associated with extrathyroidal invasion (pā€‰=ā€‰0.008). This is the first report of infiltration of nerves into the tumour microenvironment of thyroid cancer and its association with tumour aggressiveness. The role of nerves in thyroid cancer pathogenesis should be further investigated.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Nerve Growth Factor Antibody, pro, serum, ChemiconĀ®